Transition from dexmedetomidine to enteral clonidine for ICU sedation: An observational pilot study

Pharmacotherapy

Volumn 35, Issue 3, 2015, Pages 251-259

  Gagnon, David J ^a   Riker, Richard R ^a,b,c   Glisic, Elizabeth K ^a   Kelner, Andrew ^b   Perrey, Hilary M ^d   Fraser, Gilles L ^a,b  

^a MAINE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Neurosciences Institute   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

adverse effects; alpha 2 agonist; analgesia; clonidine; critical care; dexmedetomidine; intensive care; pharmacoeconomics; sedation

Indexed keywords

CLONIDINE; DEXMEDETOMIDINE; FENTANYL; LORAZEPAM; NEUROLEPTIC AGENT; OPIATE; PHENOBARBITAL; PROPOFOL; PSYCHOTROPIC AGENT; VALPROIC ACID; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; AGITATION; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DELIRIUM; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HOSPICE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; OBSERVATIONAL STUDY; PAIN; PATIENT TRANSPORT; PILOT STUDY; PROSPECTIVE STUDY; PURCHASING; REHABILITATION CARE; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEDATION; WITHDRAWAL SYNDROME; DRUG SUBSTITUTION; MIDDLE AGED; PROCEDURES; TRENDS;

AGED; CLONIDINE; DEXMEDETOMIDINE; DRUG SUBSTITUTION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84925448888     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1559     Document Type: Article

References (45)

1. Burk RS, Grap M, Munro CL, Schubert CM, Sessler CN,. Agitation onset, frequency, and associated temporal factors in critically ill adults. Am J Crit Care 2014; 23: 296-304.
2. Jaber S, Chanques G, Altairac C, et al. A prospective study of agitation in a medical-surgical ICU: incidence, risk factors, and outcomes. Chest 2005; 128: 2749-57.
3. Woods JC, Mion LC, Connor JT, et al. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med 2004; 30: 1066-72.
4. Atkins PM, Mion LC, Mendelson W, Palmer RM, Slomka J, Franko T,. Characteristics and outcomes of patients who self-extubate from ventilatory support: a case-control study. Chest 1997; 112: 1317-23.
5. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41: 263-306.
6. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301: 489-99.
7. Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012; 307: 1151-60.
8. Fraser GL, Devlin JW, Worby CP, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 2013; 41 (9 Suppl 1): S30-8.
9. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-53.
10. Wunsch H, Kahn JM, Kramer AA, et al. Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology 2010; 113: 386-94.
11. Gerlach AT, Murphy CV, Dasta JF,. An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009; 43: 2064-74.
12. Panzer O, Moitra V, Sladen RN,. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009; 25: 451-69, vii.
13. Dasta JF, Kane-Gill SL, Pencina M, et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010; 38: 497-503.
14. Dasta JF, Jacobi J, Sesti AM, McLaughlin TP,. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy 2006; 26: 798-805.
15. Bioc JJ, Magee C, Cucchi J, et al. Cost effectiveness of a benzodiazepine vs a nonbenzodiazepine-based sedation regimen for mechanically ventilated, critically ill adults. J Crit Care 2014; 29 (5): 753-757.
16. Pichot C, Ghignone M, Quintin L,. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J Intensive Care Med 2012; 27: 219-37.
17. Van der Valk J, Zeeman M, Arbouw M, Van den Oever H,. Off-label use of clonidine for sedation in Dutch ICUs. Crit Care 2014; 18 (Suppl 1): P415.
18. Jamadarkhana S, Gopal S,. Clonidine in adults as a sedative agent in the intensive care unit. J Anaesthesiol Clin Pharmacol 2010; 26: 439-45.
19. Hünseler C, Balling G, Röhlig C, et al. Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial. Pediatr Crit Care Med 2014; 15: 511-22.
20. Cunningham FE, Baughman VL, Peters J, Laurito CE,. Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth 1994; 6: 430-3.
21. Kariya N, Shindoh M, Nishi S, Yukioka H, Asada A,. Oral clonidine for sedation and analgesia in a burn patient. J Clin Anesth 1998; 10: 514-7.
22. Arenas-Lõpez S, Riphagen S, Tibby SM, et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med 2004; 30: 1625-9.
23. Duffett M, Choong K, Foster J, et al. Clonidine in the sedation of mechanically ventilated children: a pilot randomized trial. J Crit Care 2014; 29 (5): 758-763.
24. Glisic E, Riker R, Kelner A, Perrey H, Fraser G,. Transitioning patients treated with dexmedetomidine to enteral clonidine: a retrospective study [abstract]. Crit Care Med 2012; 40 (Suppl 12): A1110.
25. Whitsett TL, Chrysant SG, Dillard BL, Anton AH,. Abrupt cessation of clonidine administration: a prospective study. Am J Cardiol 1978; 41: 1285-90.
26. Weber MA,. Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents. J Cardiovasc Pharmacol 1980; 2 (Suppl 1): S73-89.
27. Hansson L, Hunyor SN, Julius S, Hoobler SW,. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J 1973; 85: 605-10.
28. Chouinard G,. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004; 65 (Suppl 5): 7-12.
29. Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S,. Clinical application of opioid equianalgesic data. Clin J Pain 2003; 19: 286-97.
30. McPherson ML,. Demystifying opioid conversion calculations: a guide for effective dosing. Bethesda, MD: American Society of Health-System Pharmacists, 2009.
31. Micromedex Healthcare Series. RED BOOK Online. Greenwood Village, CO: Truven Health Analytics; 2013. Accessed June 4, 2014.
32. Holliday SF, Kane-Gill SL, Empey PE, Buckley MS, Smithburger PL,. Interpatient variability in dexmedetomidine response: a survey of the literature. ScientificWorldJournal 2014; 2014: 805013.
33. Caumo W, Levandovski R, Hidalgo MP,. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. J Pain 2009; 10: 100-8.
34. Blaudszun G, Lysakowski C, Elia N, Tramèr MR,. Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116: 1312-22.
35. Lee C, Kim YD, Kim JN,. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol 2013; 64: 301-7.
36. Eisenach JC, De Kock M, Klimscha W,. alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology 1996; 85: 655-74.
37. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM,. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 1983; 74: 193-200.
38. Wing LM, Reid JL, Davies DS, Neill EA, Tippett P, Dollery CT,. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol 1977; 12: 463-9.
39. Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1504-13.
40. Blum RM, Stevens CA, Carter DM, et al. Implementation of a dexmedetomidine stewardship program at a tertiary academic medical center. Ann Pharmacother 2013; 47: 1400-5.
41. Marshall J, Finn CA, Theodore AC,. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008; 36: 427-33.
42. Mehta S, McCullagh I, Burry L,. Current sedation practices: lessons learned from international surveys. Crit Care Clin 2009; 25: 471-88, vii-viii.
43. Martin J, Heymann A, Bäsell K, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci 2010; 8: Doc02.
44. Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM,. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients (protocol). Cochrane Database Syst Rev 2012; 12: CD010269. doi: 10.1002/14651858.
45. Playfor S, Jenkins I, Boyles C, et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med 2006; 32: 1125-36.